Mayo Clinic Rochester · Decision guide
Rochester, Minnesota, United States · HCM, apical aneurysm and congenital disease with complex anatomy
Mayo Rochester’s surgical scope includes septal and selected apical myectomy, congenital valve reconstruction and repeat operations. Dearani’s practice connects HCM with Ebstein anomaly and paediatric/adult congenital surgery.
A programme series studied transapical myectomy together with apical aneurysm repair in 67 patients treated during 2000–2020.
That selected cohort reported estimated five-year survival of 94.5%, with median follow-up of 4.9 years.
Dearani’s profile includes Ebstein anomaly, adult and paediatric congenital surgery and multiple reoperations.
Sources: Mayo Clinic · Joseph Dearani
Programme operations · 2024-06–2025-06
Mayo Rochester adult and paediatric programme; the report uses June 2024–June 2025, not a calendar year.
Mayo 2025 Cardiovascular Surgery Annual Report ↗ · source read 2026-10-08Programme operations · Cumulative; counting cutoff not stated
Nearly 5,000 programme myectomies since the programme began in 1961. The approximate total is shown without assigning a numbered place.
Mayo 2025 Cardiovascular Surgery Annual Report ↗ · source read 2026-10-08Programme operations · Cumulative; counting cutoff not stated
Apical myectomies are part of the broader Mayo programme total, not an additional count.
Mayo 2025 Cardiovascular Surgery Annual Report ↗ · source read 2026-10-08Your diagnosis, selected specialist and treatment priorities.
Sources: Mayo · 67 patients with apical aneurysm repair · Mayo Clinic · Joseph Dearani · Mayo Clinic · HCM treatment options
Sources: Mayo · 67 patients with apical aneurysm repair · Mayo Clinic · Joseph Dearani · Mayo Clinic · HCM treatment options
Rochester, Minnesota · United States
cardiac surgeon
Joseph Dearani’s Mayo practice spans HCM, Ebstein anomaly, congenital surgery and complex reoperations. Mayo’s selected apical-myectomy research addresses a different problem from routine basal septal obstruction.
Sources: Mayo Clinic · HCM treatment options · Mayo · 67 patients with apical aneurysm repair
Read alongside Joseph A. Dearani’s profile →
The Mayo series covers transapical myectomy plus apical aneurysm repair between 2000 and 2020. Median follow-up was 4.9 years; reported estimated five-year survival was 94.5%.
How to interpret this: This selected retrospective programme cohort is not an individual surgeon score. It does not establish that all apical or nonobstructive HCM requires surgery.
Continue your guide
Free Bookimed support. Compare options before deciding.
Your diagnosis, selected specialist and treatment priorities.